1. ACGT: Advancing Clinicogenomic Trials on Cancer: Open Grid Services for Improving Medical Knowledge Discovery. EC and Japan funded R&D project. (FP6-2005-IST- 026996) http://eu-acgt.org/acgt-for-you/researchers/in-silico-oncology/oncosimulator.html and http://www.eu-acgt.org/
2. Antipas, V.P., Stamatakos, G.S., Uzunoglu, N.K.: A patient-specific in vivo tumor and normal tissue model for prediction of the response to radiotherapy: a computer simulation approach. Meth. Inf. Med. 46, 367–375 (2007)
3. Antipas, V., Stamatakos, G. S., Uzunoglu, N.K., Dionysiou, D., Dale, R.: A spatiotemporal simulation model of the response of solid tumors to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration. Phys. Med. Biol. 49, 1–20 (2004)
4. Bobola, M.S., Tseng, S.H., Blank, A., Berger, M.S., Silber, J.R.: Role of O6-methylguanine- DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin. Clin. Cancer Res. 2, 735–741 (1996)
5. Breward, C.J., Byrne, H.M., Lewis, C.E.: A multiphase model describing vascular tumour growth. Bull. Math. Biol. 65, 609–640 (2003)